{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:33:06Z","timestamp":1790886786133,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.clinthera.2022.01.016","type":"journal-article","created":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T00:25:54Z","timestamp":1649463954000},"page":"508-528","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy and Safety of SID142 in Patients With Peripheral Arterial Disease: A Multicenter, Randomized, Double-Blind, Active-Controlled, Parallel-Group, Phase III Clinical Trial"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1440-0462","authenticated-orcid":false,"given":"Hyungdon","family":"Kook","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5871-4562","authenticated-orcid":false,"given":"Cheol Woong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghoon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Hoon","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyuk","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Man","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo-Joong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9654-9257","authenticated-orcid":false,"given":"Chang Gyu","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deok-Kyu","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7236-4204","authenticated-orcid":false,"given":"Han Cheol","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7926-986X","authenticated-orcid":false,"given":"Han-Young","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In-Ho","family":"Chae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kihwan","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1528-2739","authenticated-orcid":false,"given":"Sung Gyun","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju Han","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Rok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6877-4289","authenticated-orcid":false,"given":"Jeong-Su","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok Yeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6916-4087","authenticated-orcid":false,"given":"Sang Wook","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2022.01.016_bib0001","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2147\/vhrm.2007.3.2.229","article-title":"Epidemiology, classification, and modifiable risk factors of peripheral arterial disease","volume":"3","author":"Shammas","year":"2007","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.clinthera.2022.01.016_bib0002","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.amepre.2006.12.010","article-title":"Ethnic-specific prevalence of peripheral arterial disease in the United States","volume":"32","author":"Allison","year":"2007","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.clinthera.2022.01.016_bib0003","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1161\/CIRCRESAHA.121.318535","article-title":"Epidemiology of peripheral artery disease and polyvascular disease","volume":"128","author":"Aday","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.clinthera.2022.01.016_bib0004","first-page":"e686","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"135","author":"Gerhard-Herman","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2022.01.016_bib0005","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0049-3848(90)90079-R","article-title":"Potentiation of anti-platelet aggregating activity of cilostazol with vascular endothelial cells","volume":"57","author":"Igawa","year":"1990","journal-title":"Thromb Res"},{"key":"10.1016\/j.clinthera.2022.01.016_bib0006","doi-asserted-by":"crossref","unstructured":"Manolis AA, Manolis TA, Melita H, Mikhailidis DP, Manolis AS. Update on cilostazol: a critical review of its antithrombotic and cardiovascular actions and its clinical applications [published online ahead of print October 20, 2021]. J Clin Pharmacol. 2022; 62: 320\u2013358.","DOI":"10.1002\/jcph.1988"},{"key":"10.1016\/j.clinthera.2022.01.016_bib0007","first-page":"1144","article-title":"Effect of cilostazol on platelet aggregation and experimental thrombosis","volume":"35","author":"Kimura","year":"1985","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.clinthera.2022.01.016_bib0008","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0002-9343(00)00290-4","article-title":"Ginkgo biloba: a living fossil","volume":"108","author":"Jacobs","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.clinthera.2022.01.016_bib0009","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1365-2125.1992.tb05642.x","article-title":"Ginkgo biloba for cerebral insufficiency","volume":"34","author":"Kleijnen","year":"1992","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2022.01.016_bib0010","first-page":"668","article-title":"Ginkgo biloba extract: mechanisms and clinical indications","volume":"81","author":"Diamond","year":"2000","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.clinthera.2022.01.016_bib0011","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3389\/fphar.2020.00422","article-title":"Herbal medicine for cardiovascular diseases: efficacy, mechanisms, and safety","volume":"11","author":"Shaito","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.clinthera.2022.01.016_bib0012","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0165-6147(89)90103-X","article-title":"Is there a case for PAF antagonists in the treatment of ischemic states?","volume":"10","author":"Braquet","year":"1989","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.clinthera.2022.01.016_bib0013","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0090-6980(87)90079-7","article-title":"Involvement of platelet-activating factor (PAF) in cerebral post-ischemic phase in Mongolian gerbils","volume":"34","author":"Spinnewyn","year":"1987","journal-title":"Prostaglandins"},{"key":"10.1016\/j.clinthera.2022.01.016_bib0014","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/bcp.12236","article-title":"The effect of Ginkgo biloba extracts on the pharmacokinetics and pharmacodynamics of cilostazol and its active metabolites in healthy Korean subjects","volume":"77","author":"Kim","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2022.01.016_bib0015","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.thromres.2009.02.010","article-title":"Ginkgo biloba extract enhances antiplatelet and antithrombotic effects of cilostazol without prolongation of bleeding time","volume":"124","author":"Ryu","year":"2009","journal-title":"Thromb Res"},{"key":"10.1016\/j.clinthera.2022.01.016_bib0016","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1161\/01.CIR.98.7.678","article-title":"Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial","volume":"98","author":"Dawson","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2022.01.016_bib0017","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.clinthera.2016.01.009","article-title":"Efficacy and safety of DP-R202 in patients with chronic artery occlusive disease: multicenter randomized double-blind active-controlled parallel group phase III clinical study","volume":"38","author":"Lee","year":"2016","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2022.01.016_bib0018","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1185\/03007995.2011.580340","article-title":"Fixed-dose combination of enteric-coated naproxen and immediate-release esomeprazole has comparable efficacy to celecoxib for knee osteoarthritis: two randomized trials","volume":"27","author":"Hochberg","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2022.01.016_bib0019","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.clinthera.2007.05.006","article-title":"Assessment of comparative pain relief and tolerability of SKI306X compared with celecoxib in patients with rheumatoid arthritis: a 6-week, multicenter, randomized, double-blind, double-dummy, phase III, noninferiority clinical trial","volume":"29","author":"Song","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2022.01.016_bib0020","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1177\/147323000903700632","article-title":"El-Usseini T. Efficacy and safety of celecoxib in the treatment of acute pain due to ankle sprain in a Latin American and Middle Eastern population","volume":"37","author":"Cardenas-Estrada","year":"2009","journal-title":"J Int Med Res"},{"key":"10.1016\/j.clinthera.2022.01.016_bib0021","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1368-5031.2006.00828.x","article-title":"Efficacy and tolerability of diclofenac potassium sachets in acute postoperative dental pain: a placebo-controlled, randomised, comparative study vs diclofenac potassium tablets","volume":"60","author":"Hofele","year":"2006","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.clinthera.2022.01.016_bib22","author":"Ministry of Food and Drug"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291822000467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291822000467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:57:06Z","timestamp":1758963426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291822000467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0149291822000467"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2022.01.016","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of SID142 in Patients With Peripheral Arterial Disease: A Multicenter, Randomized, Double-Blind, Active-Controlled, Parallel-Group, Phase III Clinical Trial","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2022.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}